About SEED Biosciences
SEED Biosciences is a company based in Renens (Switzerland) founded in 2018. SEED Biosciences has raised $1.53 million across 2 funding rounds from investors including FIT. SEED Biosciences offers products and services including DispenCell-S4, DispenCell-S3, and Dispen3D. SEED Biosciences operates in a competitive market with competitors including Opentrons, Tecan, Andrew Alliance, LabCyte and Ginolis, among others.
- Headquarter Renens, Switzerland
- SectorsHealthcare
- Email••••••••
- Website seedbiosciences.com
- Social LinkedIn Facebook YouTube
- Legal Name Seed Biosciences Sa
- Total Equity Funding$1.53M (USD)
in 2 rounds
- Latest Funding Round$433.78K (USD), Series A
Mar 2022
- Investors
Products & Services of SEED Biosciences
SEED Biosciences offers a comprehensive portfolio of products and services, including DispenCell-S4, DispenCell-S3, and Dispen3D.
Automated dispenser for GMP processes in regulated workflows.
Bench-top device for fast single cell seeding and monoclonality proof.
Tool for handling 3D cellular models like spheroids and organoids.
Apps and channels of SEED Biosciences
its YouTube channel SEED Biosciences has 29 subscribers and 4 videos.
Videos from SEED Biosciences
The most watched videos on SEED Biosciences's YouTube channel, SEED Biosciences (29 subscribers). Click a video to play it here.
More on SEED Biosciences.
Funding Insights of SEED Biosciences
SEED Biosciences has successfully raised a total of $1.53M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $433.78 thousand completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.53M
- Total Rounds 2
- Last Round Series A — $433,780
- First Round $1.1M
(Nov 2020)
- Investors Count 1
All 2 funding rounds of SEED Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $433,780 | Series A | – | FIT | – |
| Nov 2020 | $1.1M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in SEED Biosciences
SEED Biosciences has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include FIT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Grants and loans are provided by FIT for innovative startups. | 1994 | fondation-fit.ch | Lausanne, Switzerland |
Investor details for SEED Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of SEED Biosciences
9 people are tracked at SEED Biosciences (2 in leadership, 3 in board & advisors, 4 in team).
| Name | Role | Group |
|---|---|---|
Georges Muller | CEO & Co-founder | Leadership |
David Bonzon | CTO & Co-founder | Leadership |
Chris Radloff | Chairman Of The Board Of Directors | Board & advisors |
Jean-Luc Boulnois | Director | Board & advisors |
Piero Zucchelli | Director | Board & advisors |
Charlotte Broennimann | Buisness Development Manager | Team |
Arnaud Gelb | Application Specialist | Team |
Luc Aeberli | Application Engineer | Team |
Mathias M. | Software Engineer | Team |
Complete people profiles for SEED Biosciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SEED Biosciences
3 dated milestones of SEED Biosciences across 4 years, from founding to its latest funding, stage changes and deals.
- Founded SEED Biosciences is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Series A, of $434K.
Competitors of SEED Biosciences
SEED Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Opentrons, Tecan, Andrew Alliance, LabCyte and Ginolis, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| opentrons.com | 2013 | Brooklyn, United States | $240.56M | 177 | Pipetting robots for laboratory automation are developed. | |
| tecan.com | 1980 | Mannedorf, Switzerland | – | – | Automated laboratory instruments, robotics, and diagnostic solutions are provided. | |
| andrewalliance.com | 2011 | Vernier, Switzerland | $14.03M | 5 | Provider of automated liquid handling tools and software for scientific labs | |
| labcyte.com | 2000 | Sunnyvale, United States | $33.39M | 184 | Acoustic liquid handling is developed for life science research. | |
| ginolis.com | 2010 | Oulunsalo, Finland | $2.41M | – | Liquid handling and lab automation robots | |
| scienion.com | 2000 | Berlin, Germany | $5.67M | 114 | Non-contact dispensing solutions for genomics and proteomics are provided. | |
| alphasip.es | 2008 | Zaragoza, Spain | – | – | Nanotube-based biosensor chips are produced for real-time medical diagnostics. | |
| flow-robotics.com | 2015 | Copenhagen, Denmark | $17.15M | 16 | AI-based robots for laboratory liquid handling automation are provided. | |
| reseatech.ch | 2015 | Burgdorf, Switzerland | – | – | Fluid handling systems for biotechnology are manufactured and supplied. | |
| biotix.com | 2005 | San Diego, United States | $4.2M | 61 | Laboratory consumables and liquid handling solutions |
Detailed competitors of SEED Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SEED Biosciences
The website of SEED Biosciences (seedbiosciences.com) receives about 2K visits a month.
- Monthly visits2K
▲ 325.5% vs previous month
Latest news on Seed Biosciences
Complete news archive for SEED Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to SEED Biosciences
10 companies that operate in the same segment as SEED Biosciences (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SEED Biosciences
SEED Biosciences was founded in 2018 and raised its 1st funding round 2 years after it was founded.
SEED Biosciences is headquartered in Renens, Switzerland. It is registered at Renens, Vaud, Switzerland.
SEED Biosciences is a funded company, having raised a total of $1.53M across 2 funding rounds to date. The company's 1st funding round was a Series A of $1.1M, raised on Nov 2020.
SEED Biosciences was founded in 2018 and is located in Renens, Switzerland. Operations are centered in the biotechnology sector, where programmable robotic liquid handling systems are developed. The proprietary DispenCell technology, a pipetting robot, is employed by researchers to isolate single cells. Applications encompass biologics production, stem cell therapies, personalized medicine, and cancer diagnosis. The companys domain is seedbiosciences.com.
SEED Biosciences's top competitors include Opentrons, Tecan and Andrew Alliance.
SEED Biosciences offers DispenCell-S4, DispenCell-S3, and Dispen3D.
SEED Biosciences has 1 investor. Key investors include FIT.
SEED Biosciences operates through Seed Biosciences Sa.